As of 2024-12-15, the Intrinsic Value of Medpace Holdings Inc (MEDP) is
432.15 USD. This MEDP valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 345.93 USD, the upside of Medpace Holdings Inc is
24.90%.
The range of the Intrinsic Value is 304.18 - 803.73 USD
432.15 USD
Intrinsic Value
MEDP Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
304.18 - 803.73 |
432.15 |
24.9% |
| DCF (Growth 10y) |
404.57 - 1,031.39 |
566.16 |
63.7% |
| DCF (EBITDA 5y) |
320.51 - 396.57 |
353.10 |
2.1% |
| DCF (EBITDA 10y) |
406.33 - 527.74 |
458.70 |
32.6% |
| Fair Value |
294.13 - 294.13 |
294.13 |
-14.97% |
| P/E |
310.14 - 555.56 |
425.30 |
22.9% |
| EV/EBITDA |
197.23 - 254.96 |
222.83 |
-35.6% |
| EPV |
117.06 - 150.32 |
133.69 |
-61.4% |
| DDM - Stable |
76.47 - 236.02 |
156.25 |
-54.8% |
| DDM - Multi |
136.47 - 338.67 |
195.83 |
-43.4% |
MEDP Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
10,751.50 |
| Beta |
1.76 |
| Outstanding shares (mil) |
31.08 |
| Enterprise Value (mil) |
10,094.60 |
| Market risk premium |
4.60% |
| Cost of Equity |
10.63% |
| Cost of Debt |
4.48% |
| WACC |
7.24% |